Literature DB >> 23775725

The relationship between cerebral white matter hyperintensities and lower urinary tract function in a population based, geriatric cohort.

Clemens Wehrberger1, Susanne Jungwirth, Peter Fischer, Karl-Heinz Tragl, Wolfgang Krampla, Wehrberger Marlies, Stephan Madersbacher.   

Abstract

INTRODUCTION: White matter hyperintensities (WHM) in cerebral MRI-scan have been suspected to be involved in the pathogenesis for geriatric LUTS. Aim of this study was to investigate this association in a geriatric cohort.
MATERIALS AND METHODS: The VITA-study is a prospective, population-based study initiated 2000/2001. All inhabitants of a well-defined area in Vienna aged 75 years were recruited and underwent detailed regular visits including cerebral MRI-scans. Subcortical and periventricular WMHs were classified according to the Fazekas-classification. In 2010, all subjects alive were contacted to complete the Bristol LUTS questionnaire.
RESULTS: Two hundred seventeen participants (75 men, 142 women), all 85 years old, entered this analysis. Urgency, frequency, and nocturia was present in 39 (50.7%), 53 (52%), and 55 (73.3%) men and 79 (55.6%), 81 (78.2%), and 68 (47.9%) women, respectively. OAB symptoms were seen in 55% of women and 50% of men. At baseline, WMH were present in 68.2% and this percentage increased to 85.7% at the most recent follow-up. Several symptoms were more prevalent in participants without WMH as compared to those with WMH, (urgency: 71% vs. 53%, P=0.06, nocturia: 77% vs. 53%, P=0.01: OAB-symptoms: 71% vs. 51%, P=0.05. Only frequency was more prevalent in participants with WMH (77% vs. 68%, P=0.27). In general, sub-categorization into periventricular and subcortical WMH confirmed these data. Furthermore the amount of WMH-burden did not correlate to LUT dysfunction.
CONCLUSION: This study failed to demonstrate a clear association between several aspects of LUTS and WMH in a rather healthy, population-based 85-year-old cohort.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  LUTS; VITA; WMH; geriatric; over active bladder; white matter hyperintensities

Mesh:

Year:  2013        PMID: 23775725     DOI: 10.1002/nau.22419

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  5 in total

1.  Association between coronary artery disease severity and overactive bladder in geriatric patients.

Authors:  Muhammet Fatih Kilinc; Erdogan Yasar; Halil Ibrahim Aydin; Yildiray Yildiz; Omer Gokhan Doluoglu
Journal:  World J Urol       Date:  2017-10-14       Impact factor: 4.226

2.  The neurophysiology and seizure outcomes of late onset unexplained epilepsy.

Authors:  Rani A Sarkis; Louis Beers; Emile Farah; Mohammad Al-Akaidi; Yuxiang Zhang; Joseph J Locascio; Michael J Properzi; Aaron P Schultz; Jasmeer P Chhatwal; Keith A Johnson; Reisa A Sperling; Page B Pennell; Gad A Marshall
Journal:  Clin Neurophysiol       Date:  2020-09-19       Impact factor: 3.708

3.  Ischemic cerebrovascular burden evaluated by magnetic resonance imaging in an elderly Brazilian community: The Pietà study.

Authors:  Elisa de Paula França Resende; Luciana Costa-Silva; Karoline Carvalho Carmona; Thais Helena Machado; João Carlos Barbosa Machado; Henrique Cerqueira Guimarães; Maira Tonidandel Barbosa; Antônio Lúcio Teixeira; Leonardo Cruz de Souza; Paulo Caramelli
Journal:  eNeurologicalSci       Date:  2016-12-01

4.  Lower Urinary Tract Symptoms in Subjects with Subclinical Cerebral White Matter Lesions.

Authors:  Chi-Hang Yee; Ching Leung; Yuki Yu-Ting Wong; Sylvia Lee; Jenny Li; Pauline Kwan; Winnie Chiu-Wing Chu; Vincent Chung-Tong Mok; Chi-Fai Ng
Journal:  J Aging Res       Date:  2018-07-30

5.  Predicting Fazekas scores from automatic segmentations of white matter signal abnormalities.

Authors:  Nira Cedres; Daniel Ferreira; Alejandra Machado; Sara Shams; Simona Sacuiu; Margda Waern; Lars-Olof Wahlund; Anna Zettergren; Silke Kern; Ingmar Skoog; Eric Westman
Journal:  Aging (Albany NY)       Date:  2020-01-12       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.